---
title: "Nicaise Claude — Ownership Dossier"
canonical: https://whiteintel.dev/entity/716cc367-ed63-5832-ba7f-ac2ca0e9e805
json: https://whiteintel.dev/api/public/dossier/716cc367-ed63-5832-ba7f-ac2ca0e9e805
identifier: sec:0001644162
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Nicaise Claude

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001644162`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/716cc367-ed63-5832-ba7f-ac2ca0e9e805  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/716cc367-ed63-5832-ba7f-ac2ca0e9e805  

## Ownership & control

### Holdings / subsidiaries

- **Sarepta Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/e5124c31-cdb6-50b8-9569-bb5ec4c8c48d
- **Sarepta Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/e5124c31-cdb6-50b8-9569-bb5ec4c8c48d
- **Sarepta Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/e5124c31-cdb6-50b8-9569-bb5ec4c8c48d
- **ANCHIANO THERAPEUTICS LTD.** (director) — https://whiteintel.dev/entity/0381ce02-8845-510d-90dc-f06c29c9cd7a
- **CASSAVA SCIENCES INC** (director) — https://whiteintel.dev/entity/292c4abb-f895-5f96-aa34-5bdc3349e19a
- **Gain Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/ed881902-65a2-5e9e-9d0b-7d43e481f5a2

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Nicaise Claude**. Human view: https://whiteintel.dev/entity/716cc367-ed63-5832-ba7f-ac2ca0e9e805 · Structured JSON: https://whiteintel.dev/api/public/dossier/716cc367-ed63-5832-ba7f-ac2ca0e9e805._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._